Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Influenza, Human 16 Neoplasms 8 Leukemia, Lymphocytic, Chronic, B-Cell 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Multiple Myeloma 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Colorectal Neoplasms 4 Lymphoma, Non-Hodgkin 3 Leukemia 3 Carcinoma, Non-Small-Cell Lung 3 Recurrence 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasms, Plasma Cell 2 Melanoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Hodgkin Disease 2 Central Nervous System Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Anemia, Aplastic 2 Waldenstrom Macroglobulinemia 1 Virus Diseases 1 Vaccine-Preventable Diseases 1 Vaccination Hesitancy 1 Triple Negative Breast Neoplasms 1

Interventions

Tea 2 Bupivacaine 2 Tadalafil 1 Supine Position 1 Morphine 1 Lidocaine 1 Ketamine 1 Injections, Subcutaneous 1 Influenza Vaccines 1 Head-Down Tilt 1 Ethanol 1 Dexmedetomidine 1 Anesthetics, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Abdominal Cancer × Influenza Vaccines × Clear all

NCT02998736 2022-12-28

PERIOP-04

Ottawa Hospital Research Institute

Phase 1 Completed

Abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡